Friday, September 3, 2010
| 08:30 - 10:00 am | S 7: Infected endoprostheses I Chairmen: C. Romano, H. Winkler |
|
|---|---|---|
| S 7.1 | Invited lecture Ascherl |
15’ |
| S 7.2 | Periprosthetic Infection, Recurrence and no Pathogen to be found - Ticks of the Bugs! L. Frommelt (Hamburg, Germany) |
15’ |
| S 7.3 | Bacteriology of infected total hip arthroplasty. A review of 730 cases. H. Langvatn, O. Lutro, B. Espehaug, L. Engesæter, H. Dale, J. Schrama, G. Hallan, H. Sjursen (Bergen, Norway) |
6’ |
| S 7.4 | Risk factors for rifampin resistance of staphylococci causing
periprosthetic joint infections Y. Achermann, M. Clauss, L. Derksen, P. Raffeiner, C. Zellweger, K. Eigenmann, O. Borens, W. Zimmerli, A. Trampuz (Zürich, Switzerland) |
6' |
| S 7.5 | Prosthetic Joint Infection caused by Gram Negative Organisms C. J. Fedorka, B. Zmistowski, E. Sheehan, P. F Sharkey, J. J. Purtill, J. Parvizi (Philadelphia, USA) |
6' |
| S 7.6 | Successful Identification of Infecting Pathogens in Culture-Negative Cases of PJI B. Adeli, C. Jacovides, K. Am Jung, G. Ehrlich, J. Parvizi (Philadelphia, USA) |
6' |
| S 7.7 | Incidence of infection after primary total hip arthroplasty: Combination and assessment of data from the Norwegian Infection Surveillance System and the Norwegian Arthroplasty Register H. Dale, L. Havelin, O. Furnes, L. Engesæter, F. E. Skjeldestad, H. L. Løwer (Bergen, Norway) |
6' |
| S 7.8 | Silver coated megaendoprostheses enable limb salvage in chronic deep periprosthetic infections - a review of 12 cases T. Lovse, S. Egner, C. Wibmer, J. Friesenbichler, A. Leithner, R. Windhager (Graz, Austria) |
6' |
| S 7.9 | Combined 99mTc-Sulesomab and 99mTc-nanocolloids bone marrow imaging for the diagnosis of infected joint replacement R. Sousa, M. Massada, A. Pereira, D. Freitas, F. Fontes, I. Amorim (Porto, Portugal) |
6' |
| Total discussion | 18’ | |
| 10:00 - 10:30 am | Break and exhibition | |
| 10:30 am - 12:15 pm | S 8: Basic science I Chairmen:A. Trampuz, G. Walenkamp |
|
| S 8.1 | Invited lecture: New molecular methods for the detection and identification of bacteria in orthopaedic infections B. Costerton (Pittsburgh, USA) |
45’ |
| S 8.3 | Invited lecture: Host defense strategies C. Wagner (Ludwigshafen, Germany) |
15’ |
| S 8.4 | Staphylococcal biofilm formation on cancellous bone grafts – an in-vitro study M. Clauss, U. Furustrand, A. Bizzini, A. Trampuz, T. Ilchmann (Liestal, Switzerland) |
6' |
| S 8.5 | Adherence of Staphylococcus aureus to non biological surfaces:
influence of human serum and plasma proteins S. Aytaç, V. Heppert, C. Wagner, G. M. Hänsch (Ludwigshafen, Germany) |
6' |
| S 8.6 | Risk-Assessment in Septic Surgery based on Immune-Mapping.
Is Success predictable? W. Mueller, U. Sack, G. O. Hofmann, A. Tiemann (Halle, Germany) |
6' |
| S 8.7 | Anti-bacterial finishing of hospital textiles for nosocomial infections prevention. An experimental study. L. Drago, E. De Vecchi, F. Dell'Oro, D. Romanò, C.L. Romanò (Milano, Italy) |
6' |
| Total discussion | 21’ | |
| 12:15 - 01:00 pm | S 9: Osteomyelitis therapy in third world countries Chairman: G. Lob |
|
| S 9.1 | Invited lecture: Osteomyelitis therapy for children in third world countries – problems and results O. Wamsler (Gelsenkirchen, Germany) |
20’ |
| S 9.2 | Implementation of a Bone an Joint Infection Unit in a Developing Country R. Tibau, X. Manubens, N. Joshi, G. Avarez-Uria, L. Lorenzo, I. Picazo (Mataró, Spain) |
15’ |
| Total discussion | 10’ | |
| 01:00 - 02:00 pm | Break and exhibition or lunch symposium Biomet Deutschland GmbH | |
| 02:00 - 03:15 pm | S 10: Basic science II Chairmen: C. Wagner, A. Soriano |
|
| S 10.1 | Invited lecture n.N. |
15’ |
| S 10.2 | Invited lecture: Systemic antibiotic therapy of prosthetic joint infections A. Trampuz (Lausanne, Switzerland) |
15’ |
| S 10.3 | Induction of activation associated receptors and Toll-like receptors on activated T cells in response to persistent bacterial infection D. Kotsougiani, M. Pioch, K. Kondella, B. Prior, V. Heppert, G.-M. Hänsch, C. Wagner (Ludwigshafen, Germany) |
6’ |
| S 10.4 | Alloplastic materials and their propensity to infection R. Ballay, I. Landor, F. Ržika, D. Jahoda, A. Sosna (Prague, Czech Republic) |
6’ |
| S 10.5 | Maggot excretions suppress the complement system |
6’ |
| S 10.6 | Single Nucleotide Polymorphisms in MBL2 predispose to infectious complications in polytrauma patients M. W. Bronkhorst, P. Patka, E.M.M. van Lieshout (Rotterdam, Netherlands) |
6’ |
| S 10.7 | A novel antibacterial biomaterials containing silver
- Evaluation of biofilm formation under flow condition - Y. Ando, I. Noda, H. Miyamoto, Y. Yonekura, T. Shimazaki, M. Miyazaki, M. Mawatari, T. Hotokebuchi (Osaka, Japan) |
6’ |
| S 10.8 | Biomechanical testing of supercritical carbondioxide treated / gamma sterilized human cancellous bone grafts U. Burner, K.Kaudela, C.Bonfert, J.Schwiedrzik, E.Dall’Ara, P.Zysset, H.Winkler (Wels, Austria) |
6’ |
| Total Discussion | 9’ | |
| 03:15 - 03:30 pm | Poster session II Chair: O. Borens, C. Vogely |
|
| 03:15 - 03:45 pm | Break and exhibition | |
| 03:45 - 04:00 pm | EBJIS Fellowship EBJIS Travelling Fellowship: First records |
|
| 04:00 - 05:30 pm | S 11: Free papers II Chairmen: G. Schmidmaier, C. Wagner |
|
| S 11.1 | Antibacterial bioactive glass S53P4 as bone graft substitute in treatment of osteomyelitis N. Lindfors, P. Hyvönen, M. Nyyssönen, M. Kirjavainen, J. Kankare, E. Gullichsen, J. Salo (Helsinki, Finnland) |
6’ |
| S 11.2 | Next generation antibacterial HA coating? In vitro and in vivo study of osteocoductivity? I. Noda, Y. Ando, H. Miyamoto, T. Shimazaki, Y. Yonekura, M. Miyazaki, M. Mawatari, T. Hotokebuchi (Osaka, Japan) |
6’ |
| S 11.3 | Prevention of fungus infections in silver-coated tumoural prosthesis: experimental in vitro study, preliminary reports M. A. Rosa, M. Sanguinetti, S. Mauro, S. Barreca, L. Fisichella, G. Maccauro (Messina, Italy) |
6’ |
| S 11.4 | The value of pre-operative percutaneous bone-prosthesis interface biopsy (BPIB) in the diagnosis of an infected prosthetic joint: a retrospective preliminary study E. Gil Rodriguez, J. Roman Verdasco, P. Salvador Corona Pérez-Cardona, C. Amat Mateu, E. Guerra Farfan, X. Flores Sanchez (Barcelona, Spain) |
6’ |
| S 11.5 | Two stage treatment of infected megaprostheses for bone tumors: an update of the Rizzoli experience and a new proposed protocol for antibiotic prophylaxis P. Ruggieri, A. Angelini, A. Maso, E. Pala, T. Calabrò, M. Romantini, G. Drago, M. Mercuri (Bologna, Italy) |
6’ |
| S 11.6 | New Diagnostic Criteria for Periprosthetic Joint Infection: The Importance of WBC Count and PMN% in the Joint Aspirate K. Am Jung, J. Parvizi, C. Jacovides, B. Zmistowski (Philadelphia, USA) |
6’ |
| S 11.7 | Does post-operative fever have any relationship to periprosthetic joint infection? C. Restrepo, P. Hansen, K. Kent, B. Zmistowski, J. Parvizi (Philadelphia, USA) |
6’ |
| S 11.8 | The new model of PCR diagnostic scheme for individual choice of infected arthroplasty treatment method D. Jahoda, T. Hudec, D. Pokorný, I. Landor, M. Hein, A. Sosna (Prague, Czech Republic) |
6’ |
| S 11.9 | Combined Positron Emission Tomography using Gallium 68 with Computed Tomography and use of Antibiotic containing Hydroxyapatite Pallets in the treatment of bone infections. C. Errani, E. Staals, A. Toscano, A. Biazzo, N. Alì, A. Angelini, E. Pala, G. Guerra, C. Nanni, S. Fanti, P. Ruggieri, M. Mercuri (Bologna, Italy) |
6’ |
| S 11.10 | Using the RIA Device. Our Initial Experience T. Mut, S. Cervelló, F. Lucas, I.Moreno, S. Burguet (Valencia, Spain) |
6’ |
| S 11.11 | Risk factors in treatment of chronic infection in total knee arthroplastie in patients with serious systemic disease R. Pätzold, U.Spiegl, J. Friederichs, M. Militz, V. Bühren (Murnau, Germany) |
6’ |
| S 11.12 | Management of wound complications after total knee arthroplasty G. Fuhrmann (Stolzalpe, Austria) |
6’ |
| Total discussion | 12’ | |
| 05:30 - 07:00 pm | General assembly | |
| 08:30 pm | Gala dinner | |
